| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1887db224628cb856f0de5a6d790026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d493a58d0ff411afd3173c347d323d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b9212963dd096956ac0fc9cf858e262 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-71 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2016-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f269c8ebc29f991d60b796c942c1058a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d0bfdcf8a86405295c27091de142eed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_395ce321a2d673c2b1196b6057832c4b |
| publicationDate |
2017-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201718641-A |
| titleOfInvention |
Anti-vascular endothelial growth factor receptor 2 (VEGFR2) antibody |
| abstract |
The present invention provides an anti-vascular endothelial growth factor receptor 2 (VEGFR2) antibody and an antigen-binding fragment thereof. Isolated nucleic acid molecules, related expression vectors, and host cells encoding such anti-VEGFR2 antibodies or antigen-binding fragments thereof are also provided. Methods of making anti-VEGFR2 antibodies and antigen-binding fragments thereof are provided. Related pharmaceutical compositions comprising an anti-VEGFR2 antibody (or antigen-binding fragment thereof) and methods for treating a pathological condition characterized by excessive angiogenesis are also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10138300-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I665213-B |
| priorityDate |
2015-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |